These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15344563)

  • 1. [Evaluation of the withdrawal of ACE inhibitors in coronary artery surgery].
    Tamayo E; Di Stefano S; Carassiti M; Flórez S; Carrascal Y; Agrò F
    Clin Ter; 2004 May; 155(5):171-4. PubMed ID: 15344563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
    Benedetto U; Melina G; Capuano F; Comito C; Bianchini R; Simon C; Refice S; Angeloni E; Sinatra R
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1098-103. PubMed ID: 18852580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
    Ahmad M; White R; Tan J; Huang BS; Leenen FH
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
    Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
    Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitor therapy for coronary artery disease and diabetes mellitus.
    McConnell KJ; Zadvorny EB; Denham AM; Kasten SL; Hutka KA; Koetting CR; Merenich JA;
    Am J Manag Care; 2007 Oct; 13(10):560-6. PubMed ID: 17927460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes of death in the ATLAS study: effects of high-dose ACE inhibitors.
    Cleland JG
    Int J Clin Pract Suppl; 1999 Apr; 100():19-20. PubMed ID: 10658295
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease.
    Imaizumi S; Miura S; Nishikawa H; Iwata A; Zhang B; Kawamura A; Tsuchiya Y; Kumagai K; Matsuo K; Saku K
    Hypertens Res; 2006 Mar; 29(3):135-41. PubMed ID: 16755148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
    Kincaid EH; Ashburn DA; Hoyle JR; Reichert MG; Hammon JW; Kon ND
    Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up.
    Eveson DJ; Robinson TG; Potter JF
    Am J Hypertens; 2007 Mar; 20(3):270-7. PubMed ID: 17324738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial.
    Pedrazzini G; Santoro E; Latini R; Fromm L; Franzosi MG; Mocetti T; Staszewsky L; Barlera S; Tognoni G; Maggioni AP;
    Am Heart J; 2008 Feb; 155(2):388-94. PubMed ID: 18215613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulators.
    Apostolakis S; Krambovitis E; Vlata Z; Kochiadakis GE; Baritaki S; Spandidos DA
    Thromb Res; 2007; 121(3):387-95. PubMed ID: 17521710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study.
    Etminan M; Zhang B; Fitzgerald M; Brophy JM
    Pharmacotherapy; 2006 Apr; 26(4):479-82. PubMed ID: 16553505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleural effusions, water balance mediators and the influence of lisinopril after completion Fontan procedures.
    François K; Bové T; De Groote K; Panzer J; Vandekerckhove K; Suys B; De Wolf D; Van Nooten G
    Eur J Cardiothorac Surg; 2009 Jul; 36(1):57-62. PubMed ID: 19369086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of an angiotensin converting enzyme inhibitor on intestinal wound healing.
    Ilhan YS; Bulbuller N; Kirkil C; Ozercan R; Seckin D
    J Surg Res; 2005 Sep; 128(1):61-5. PubMed ID: 15869762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
    van Gilst WH; Warnica JW; Baillot R; Johnstone D; Calciu CD; Block P; Myers MG; Chocron S; Rouleau JL;
    Am Heart J; 2006 Jun; 151(6):1240-6. PubMed ID: 16781228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.